(P016) A Phase I/II Trial of 5-Fraction Stereotactic Radiosurgery With 5MM Margins With Concurrent and Adjuvant Temozolomide in Newly Diagnosed Supratentorial Glioblastoma: Quality of Life and Updated Outcomes

Authors :: D.K. Fujimoto
Gordon Li
Sara A. Dudley
Reena Thomas
Erqi L. Pollom
Lisa R Jacobs
John R. Adler
Clara Y.H. Choi
Jacob Wynne
Kira Seiger
Steven L. Chang
Seema Nagpal
Scott G. Soltys
Iris C. Gibbs
Steven L. Hancock
Melissa Azoulay
Leslie M. Modlin
Laurie Tupper
Griffith R. Harsh
Ciara Harraher
Source :: International Journal of Radiation Oncology*Biology*Physics. 98:E19-E20
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: Cancer Research
medicine.medical_specialty
Radiation
Temozolomide
business.industry
medicine.medical_treatment
Newly diagnosed
Radiosurgery
Surgery
Phase i ii
Oncology
Quality of life
medicine
Radiology, Nuclear Medicine and imaging
Radiology
business
Adjuvant
Supratentorial Glioblastoma
medicine.drug

Full Text Access

Tools